Literature DB >> 24474631

Recurrence location after resection of colorectal liver metastases influences prognosis.

K M Govaert1, C S van Kessel, E J A Steller, B L Emmink, I Q Molenaar, O Kranenburg, R van Hillegersberg, I H M Borel Rinkes.   

Abstract

AIM: To assess the impact of first recurrence location on survival following surgery of colorectal liver metastases.
METHODS: A total of 265 consecutive patients with colorectal liver metastases undergoing liver surgery (2000-2011) were categorized according to first site of tumor recurrence. Time to recurrence (TTR) and overall survival (OS) were determined. Uni- and multivariate analysis were performed to identify factors associated with TTR and OS.
RESULTS: Median TTR was 1.16 years following liver resection, and 0.56 years following radiofrequency ablation (RFA). Intrahepatic recurrence following liver resection resulted in a significantly shorter median TTR compared to extrahepatic recurrence. Intrapulmonary recurrence was associated with superior survival compared to other recurrence locations. Such patterns were not observed in the RFA-treated group. Multivariate analysis identified the type of surgical treatment and extra-hepatic first-site recurrence (other than lung) as independent predictors for OS. Pre-operative chemotherapy and simultaneous intrahepatic and extrahepatic recurrence were independent predictors for both TTR and OS.
CONCLUSIONS: Patients with intrahepatic recurrence following liver resection have a significantly shorter TTR and OS when compared to patients developing extrahepatic recurrence. Pulmonary recurrence following resection is associated with longer survival. Simultaneous intra- and extrahepatic recurrence is an independent prognostic factor for TTR and OS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24474631     DOI: 10.1007/s11605-014-2461-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  40 in total

1.  Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases.

Authors:  Michael D'Angelica; Peter Kornprat; Mithat Gonen; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2010-11-02       Impact factor: 5.344

Review 2.  Ablative therapies for colorectal liver metastases: a systematic review.

Authors:  S Pathak; R Jones; J M F Tang; C Parmar; S Fenwick; H Malik; G Poston
Journal:  Colorectal Dis       Date:  2011-09       Impact factor: 3.788

3.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

4.  Immunohistochemically detected hepatic micrometastases predict a high risk of intrahepatic recurrence after resection of colorectal carcinoma liver metastases.

Authors:  Naoyuki Yokoyama; Yoshio Shirai; Yoich Ajioka; Shigenori Nagakura; Takeyasu Suda; Katsuyoshi Hatakeyama
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

Review 5.  Cytokines, inflammation and colon cancer.

Authors:  Lidija Klampfer
Journal:  Curr Cancer Drug Targets       Date:  2011-05       Impact factor: 3.428

6.  Evidence of heterogeneity within colorectal liver metastases for allelic losses, mRNA level expression and in vitro response to chemotherapeutic agents.

Authors:  Nicolas Goasguen; Cecile de Chaisemartin; Antoine Brouquet; Catherine Julié; Gregoire P Prevost; Pierre Laurent-Puig; Christophe Penna
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

7.  Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases.

Authors:  Andrew McKay; Katherine Fradette; Jeremy Lipschitz
Journal:  HPB Surg       Date:  2010-02-01

8.  Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases.

Authors:  Hyuk Hur; Yong Taek Ko; Byung Soh Min; Kyung Sik Kim; Jin Sub Choi; Seung Kook Sohn; Chang Hwan Cho; Heung Kyu Ko; Jong Tai Lee; Nam Kyu Kim
Journal:  Am J Surg       Date:  2008-09-11       Impact factor: 2.565

9.  Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis.

Authors:  Toshifumi Wakai; Yoshio Shirai; Jun Sakata; Vladimir A Valera; Pavel V Korita; Kouhei Akazawa; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  Ann Surg Oncol       Date:  2008-07-02       Impact factor: 5.344

Review 10.  Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.

Authors:  Nikolas H Stoecklein; Christoph A Klein
Journal:  Int J Cancer       Date:  2010-02-01       Impact factor: 7.396

View more
  4 in total

Review 1.  The Interaction Between Epigenetic Changes, EMT, and Exosomes in Predicting Metastasis of Colorectal Cancers (CRC).

Authors:  Meiqi Yang; Mingjun Sun; Huijing Zhang
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

2.  Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.

Authors:  Siân A Pugh; Megan Bowers; Alexandre Ball; Stephen Falk; Meg Finch-Jones; Juan W Valle; Derek A O'Reilly; Ajith K Siriwardena; Joanne Hornbuckle; Myrddin Rees; Charlotte Rees; Tim Iveson; Tamas Hickish; Tom Maishman; Louise Stanton; Elizabeth Dixon; Andrea Corkhill; Mike Radford; O James Garden; David Cunningham; Tim S Maughan; John A Bridgewater; John N Primrose
Journal:  Br J Cancer       Date:  2016-07-19       Impact factor: 7.640

3.  18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases.

Authors:  M Samim; W Prevoo; B J de Wit-van der Veen; K F Kuhlmann; T Ruers; R van Hillegersberg; M A A J van den Bosch; H M Verkooijen; M G E H Lam; M P M Stokkel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-02-08       Impact factor: 9.236

4.  Hepatic thermal injury promotes colorectal cancer engraftment in C57/black 6 mice.

Authors:  Alison L Halpern; J Gregory Fitz; Yuki Fujiwara; Jeniann Yi; Aimee L Anderson; Yuwen Zhu; Richard D Schulick; Karim C El Kasmi; Carlton C Barnett
Journal:  Am J Physiol Cell Physiol       Date:  2020-11-11       Impact factor: 4.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.